Your browser doesn't support javascript.
loading
Endothelin levels in experimental diabetes combined with cardiac hypertrophy.
Skoumal, Réka; Seres, Leila; Soós, Pál; Balogh, Eva; Kovàts, Tìmea; Rysa, Jaana; Ruskoaho, Heikki; Tóth, Miklós; Horkay, Ferenc.
Afiliación
  • Skoumal R; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary. sreka78@hotmail.com
J Cardiovasc Pharmacol ; 44 Suppl 1: S195-7, 2004 Nov.
Article en En | MEDLINE | ID: mdl-15838277
Diabetes mellitus is associated with endothelial and cardiac dysfunction, and endothelin has been suggested to alter cardiac function by being a positive inotropic agent, modulating the Frank-Starling response, contracting the coronary arteries and inducing tissue proliferation. We investigated endothelin levels in diabetic and in healthy dogs, 1 and 3 days after placing arteriovenous shunts (8 weeks after diabetes induction) in the femoral regions. Right and left ventricular weight/body weight ratios and Nterminal- atrial natriuretic peptide were increased in shunted animals (P < 0.05). Plasma endothelin levels were comparable in healthy and diabetic dogs. Shunted circulation did not change systemic endothelin levels in healthy dogs but reduced endothelin levels in diabetic dogs. The functional significance of altered endothelin responses to acute hemodynamic burden in experimental diabetes needs further investigation.
Asunto(s)
Buscar en Google
Base de datos: MEDLINE Asunto principal: Cardiomegalia / Endotelina-1 / Diabetes Mellitus Experimental Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cardiovasc Pharmacol Año: 2004 Tipo del documento: Article
Buscar en Google
Base de datos: MEDLINE Asunto principal: Cardiomegalia / Endotelina-1 / Diabetes Mellitus Experimental Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cardiovasc Pharmacol Año: 2004 Tipo del documento: Article